Cigna Due Diligence Report

Top-tier US health insurer and global health services company. Approximately $235B revenue across Evernorth (PBM, specialty pharmacy, care services) and Cigna Healthcare. Sold Medicare Advantage business to HCSC for $3.7B to focus on commercial and Evernorth-led services. Express Scripts PBM is the second-largest in the US.

What Our Cigna Diligence Report Covers

• Business Overview — Revenue model, key products/services, market position, and growth trajectory
• Financial Snapshot — Revenue, profitability margins, balance sheet health, and cash position
• Risk Flags — Regulatory exposure, litigation, customer concentration, and supply chain dependencies
• Competitive Landscape — Key competitors, market share dynamics, and competitive moats
• Management Assessment — Leadership track record, insider ownership, and governance quality
• Recent Developments — Latest news, product launches, M&A activity, and strategic shifts
• Diligence Score — Overall quantitative score (0-100) with component breakdowns

Full Report Also Includes

• Detailed 3-year financial analysis with trend projections
• Comparable transactions and precedent deal multiples
• Risk register with probability and impact ratings
• Regulatory and compliance deep-dive
• Investment committee workplan template